Send to

Choose Destination
J Child Neurol. 2016 Dec;31(14):1534-1539. Epub 2016 Aug 29.

Utility of Whole Exome Sequencing for Genetic Diagnosis of Previously Undiagnosed Pediatric Neurology Patients.

Author information

Metabolic-Neurogenetic Service, Wolfson Medical Center, Holon, Israel
Institute of Medical Genetics, Wolfson Medical Center, Holon, Israel.
Metabolic-Neurogenetic Service, Wolfson Medical Center, Holon, Israel.
Department of Pediatric Neurology, Wolfson Medical Center, Holon, Israel.
Molecular Genetics laboratory, Wolfson Medical Center, Holon, Israel.


Whole exome sequencing enables scanning a large number of genes for relatively low costs. The authors investigate its use for previously undiagnosed pediatric neurological patients. This retrospective cohort study performed whole exome sequencing on 57 patients of "Magen" neurogenetic clinics, with unknown diagnoses despite previous workup. The authors report on clinical features, causative genes, and treatment modifications and provide an analysis of whole exome sequencing utility per primary clinical feature. A causative gene was identified in 49.1% of patients, of which 17 had an autosomal dominant mutation, 9 autosomal recessive, and 2 X-linked. The highest rate of positive diagnosis was found for patients with developmental delay, ataxia, or suspected neuromuscular disease. Whole exome sequencing warranted a definitive change of treatment for 5 patients. Genetic databases were updated accordingly. In conclusion, whole exome sequencing is useful in obtaining a high detection rate for previously undiagnosed disorders. Use of this technique could affect diagnosis, treatment, and prognostics for both patients and relatives.


ataxia; developmental delay; exomics; genetics; neurology

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center